Published : Oct-2017
No. of Pages : 358
1 Table of Contents 2
1.1 List of Tables 9
1.2 List of Figures 16
2 Introduction 17
2.1 Aesthetic Devices Overview 17
3 Products under Development 18
3.1 Aesthetic Devices - Pipeline Products by Stage of Development 18
3.2 Aesthetic Devices - Pipeline Products by Segment 19
3.3 Aesthetic Devices - Pipeline Products by Territory 20
3.4 Aesthetic Devices - Pipeline Products by Regulatory Path 21
3.5 Aesthetic Devices - Pipeline Products by Estimated Approval Date 22
3.6 Aesthetic Devices - Ongoing Clinical Trials 23
4 Aesthetic Devices - Pipeline Products under Development by Companies 24
4.1 Aesthetic Devices Companies - Pipeline Products by Stage of Development 24
4.2 Aesthetic Devices - Pipeline Products by Stage of Development 27
5 Aesthetic Devices Companies and Product Overview 31
5.1 Acelity L.P. Inc. Company Overview 31
5.2 Aeon Astron Corporation Company Overview 32
5.3 Aesthetic Medical Device Company Overview 33
5.4 Aesthetics Point Ltd. Company Overview 35
5.5 Allergan Inc Company Overview 36
5.6 Allergan Plc Company Overview 43
5.7 Almirall Ltd Company Overview 46
5.8 Ambicare Health Ltd Company Overview 47
5.9 Andrew Technology LLC Company Overview 48
5.10 Anika Therapeutics Inc Company Overview 49
5.11 Apogee Aesthetic Technologies Company Overview 50
5.12 Avita Medical Ltd Company Overview 51
5.13 Bellus Medical, LLC Company Overview 54
5.14 BioPhotas, Inc. Company Overview 58
5.15 Biosculpture Technology, Inc. Company Overview 59
5.16 BioTime Inc Company Overview 61
5.17 Bioxis Pharmaceuticals Company Overview 65
5.18 Celltrix AB Company Overview 68
5.19 Cutera Inc Company Overview 69
5.20 Cytophil, Inc. Company Overview 74
5.21 Cytori Therapeutics Inc Company Overview 75
5.22 Cytrellis Biosystems Inc Company Overview 76
5.23 Dermele Skin Care, LLC Company Overview 77
5.24 Eclipse Aesthetics LLC Company Overview 78
5.25 Ellman International Inc Company Overview 80
5.26 Energist Ltd Company Overview 81
5.27 Erchonia Corp Company Overview 82
5.28 Eternity Healthcare Inc. Company Overview 83
5.29 EternoGen Aesthetics LLC Company Overview 84
5.30 FibroGen Inc Company Overview 85
5.31 Forticell Bioscience Inc Company Overview 86
5.32 Fourth State Medicine Ltd Company Overview 87
5.33 Galderma SA Company Overview 88
5.34 Genethia Phrima SRL Company Overview 95
5.35 Genzyme Corp Company Overview 96
5.36 Hologic Inc Company Overview 97
5.37 ImpLite Ltd. Company Overview 98
5.38 Innovia LLC Company Overview 99
5.39 IonMed Ltd. Company Overview 101
5.40 Juvenis Ltd Company Overview 102
5.41 Keraderm LLC Company Overview 103
5.42 Khorionyx SA Company Overview 104
5.43 L&C Bio Company Overview 105
5.44 Medifirst Solutions Inc Company Overview 106
5.45 Medixsysteme Company Overview 107
5.46 Mentor Worldwide LLC Company Overview 110
5.47 Merz Pharma GmbH & Co KgaA Company Overview 111
5.48 Moma Therapeutics, Inc. Company Overview 113
5.49 Mosaic Medical Technologies, Inc Company Overview 114
5.50 NanoVibronix Inc Company Overview 115
5.51 Neosthetic, LLC Company Overview 116
5.52 NivaSonix, LLC Company Overview 117
5.53 Northwestern University Company Overview 118
5.54 Nu Skin International Inc. Company Overview 119
5.55 Oligo Medic, Inc. Company Overview 121
5.56 ORGEV Laboratories Company Overview 122
5.57 PetVivo Holdings Inc Company Overview 124
5.58 PhotoDerma SA Company Overview 126
5.59 PhotoMedex Inc Company Overview 128
5.60 PhotoSonix Medical, Inc. Company Overview 131
5.61 Pinnacle Therapeutics Company Overview 132
5.62 PolyNovo Biomaterials Pty Ltd Company Overview 133
5.63 PS Advanced Engineering Company Overview 136
5.64 SANUWAVE Health Inc Company Overview 138
5.65 Sebacia Inc Company Overview 141
5.66 Sekisui Medical Co Ltd Company Overview 144
5.67 Serene Medical, Inc. Company Overview 145
5.68 Shanghai Haohai Biological Technology Co Ltd Company Overview 146
5.69 SharpLight Company Overview 148
5.70 Shin Poong PharmCo Ltd Company Overview 150
5.71 Sienna Biopharmaceuticals Inc Company Overview 151
5.72 Sinclair Pharma PLC Company Overview 154
5.73 Slender Medical Ltd. Company Overview 165
5.74 Sofregen Medical Inc Company Overview 167
5.75 Southern Illinois University Carbondale Company Overview 168
5.76 Stratpharma AG Company Overview 169
5.77 Suneva Medical Inc Company Overview 170
5.78 Sybaritic Inc Company Overview 173
5.79 Syneron Medical Ltd Company Overview 174
5.80 TEI Biosciences Inc Company Overview 179
5.81 University of California Irvine Company Overview 180
5.82 University of California Santa Barbara Company Overview 181
5.83 Valeant Pharmaceuticals International Inc Company Overview 182
5.84 Zeltiq Aesthetics Inc Company Overview 187
6 Aesthetic Devices- Recent Developments 190
6.1 Sep 01, 2017: Prollenium Medical Technologies Announces the Appointment of its New President of US Operations, Sean L. Wilson 190
6.2 Aug 31, 2017: Avita Medical Names Erin Liberto as Chief Commercial Officer 190
6.3 Aug 30, 2017: New Study: iGrow Plus Minoxidil Accelerates Hair Growth 190
6.4 Aug 28, 2017: Anika Announces Appointment of Steven Chartier as Vice President of Regulatory and Clinical Affairs 191
6.5 Aug 23, 2017: Misonix Appoints Joseph Dwyer as Chief Financial Officer 192
6.6 Aug 22, 2017: Misonix Reports Fiscal Year 2017 Financial Results 193
6.7 Aug 21, 2017: Cutera Strengthens Leadership Team with Two Key Executive Appointments 194
6.8 Aug 18, 2017: Cutera Announces Retirement of Jerry P. Widman as Member of the Board of Directors 194
6.9 Aug 17, 2017: Prollenium Medical Technologies announces U.S. FDA approval for its cross-linked hyaluronic acid dermal filler 195
6.10 Aug 14, 2017: SANUWAVE Health Reports Second Quarter Financial Results and Provides a Business Update 195
6.11 Aug 10, 2017: Cytori Reports Second Quarter 2017 Business and Financial Results 197
6.12 Aug 10, 2017: AirXpanders: Half-Yearly Report 198
6.13 Aug 08, 2017: Penumbra Reports Second Quarter 2017 Financial Results 199
6.14 Aug 08, 2017: Valeant Announces Second-Quarter 2017 Results 199
6.15 Aug 08, 2017: Medifirst Appoints Executive Advisor for China 202
6.16 Aug 07, 2017: FibroGen Reports Second Quarter 2017 Financial Results 203
6.17 Aug 07, 2017: Cutera Reports Second Quarter 2017 Financial Performance, Increases Revenue and EPS Guidance 204
6.18 Aug 04, 2017: Medifirst Solutions Signs Distribution Agreement 205
6.19 Aug 02, 2017: Revance appoints new chief commercial officer and president of Aesthetics & Therapeutics 205
6.20 Jul 27, 2017: Zimmer Biomet Reports Second Quarter 2017 Financial Results 206
6.21 Jul 27, 2017: Smith & Nephew Second Quarter and First Half 2017 Results 207
6.22 Jul 27, 2017: Anika Announces Appointment of Joseph Darling as President 210
6.23 Jul 27, 2017: Quantel: First-Half Revenues Up 4.8% 211
6.24 Jul 26, 2017: Anika Reports Strong Second Quarter 2017 Financial Results 212
6.25 Jul 25, 2017: Histogen's Growth Factor Technology to be Marketed as Part of Allergan Skin Care Line 213
6.26 Jul 19, 2017: Merz To Consolidate Operations in Racine County, Create Up To 20 Jobs 213
6.27 Jul 12, 2017: Cutera Announces Engagement of Sandy Gardiner as Consultant CFO 214
6.28 Jul 11, 2017: CE Mark Signals Expansion of SkinPen Microneedling System to Europe 214
6.29 Jul 11, 2017: Zimmer Biomet Announces Leadership Transition 215
6.30 Jul 11, 2017: Zimmer Biomet Reports Certain Preliminary Second Quarter 2017 Results 215
6.31 Jul 11, 2017: Sinclair Pharma: Trading Update for the 6 months to 30 June 2017 216
6.32 Jul 05, 2017: Penumbra Promotes Daniel Davis to Chief Commercial Officer 217
6.33 Jul 04, 2017: Appointment of Angie Risley as Non-Executive Director and Chairman Elect of the Remuneration Committee 217
7 Appendix 353
7.1 Methodology 353
7.2 About GlobalData 356
7.3 Contact Us 356
7.4 Disclaimer 356
1.1 List of Tables
Table 1: Aesthetic Devices - Pipeline Products by Stage of Development 20
Table 2: Aesthetic Devices - Pipeline Products by Segment 21
Table 3: Aesthetic Devices - Pipeline Products by Territory 22
Table 4: Aesthetic Devices - Pipeline Products by Regulatory Path 23
Table 5: Aesthetic Devices - Pipeline Products by Estimated Approval Date 24
Table 6: Aesthetic Devices - Ongoing Clinical Trials 25
Table 7: Aesthetic Devices Companies - Pipeline Products by Stage of Development 26
Table 8: Aesthetic Devices - Pipeline Products by Stage of Development 29
Table 9: Acelity L.P. Inc. Pipeline Products & Ongoing Clinical Trials Overview 33
Table 10: Strattice For Facelift - Product Status 33
Table 11: Strattice For Facelift - Product Description 33
Table 12: Aeon Astron Corporation Pipeline Products & Ongoing Clinical Trials Overview 34
Table 13: BioDermal Filler - Product Status 34
Table 14: BioDermal Filler - Product Description 34
Table 15: Aesthetic Medical Device Pipeline Products & Ongoing Clinical Trials Overview 35
Table 16: Alluris - Product Status 35
Table 17: Alluris - Product Description 35
Table 18: Skinlumina - Product Status 36
Table 19: Skinlumina - Product Description 36
Table 20: Aesthetics Point Ltd. Pipeline Products & Ongoing Clinical Trials Overview 37
Table 21: Juvence Implant - Product Status 37
Table 22: Juvence Implant - Product Description 37
Table 23: Allergan Inc Pipeline Products & Ongoing Clinical Trials Overview 38
Table 24: Eplica Silk - Product Status 38
Table 25: Eplica Silk - Product Description 38
Table 26: JUVEDERM Volbella - Product Status 39
Table 27: JUVEDERM Volbella - Product Description 39
Table 28: Juvederm Vollure XC - Product Status 39
Table 29: Juvederm Vollure XC - Product Description 40
Table 30: Juvederm VOLUMA XC - Product Status 40
Table 31: Juvederm VOLUMA XC - Product Description 40
Table 32: SeriGel - Product Status 41
Table 33: SeriGel - Product Description 41
Table 34: Allergan Inc - Ongoing Clinical Trials Overview 42
Table 35: Juvederm VOLUMA XC - Clinical Study of Neuramis Volume Lidocaine to Evaluate the Efficacy and Safety for Temporary Restoring the Mid-face Volume 43
Table 36: Juvederm VOLUMA XC - Juvederm Voluma XC for the Treatment of Hypoplastic Chin 43
Table 37: Juvederm Vollure XC - A Safety and Efficacy Study of JUVEDERM VOLIFT with Lidocaine and Restylane for Nasolabial Folds in Chinese Adults 44
Table 38: Allergan Plc Pipeline Products & Ongoing Clinical Trials Overview 45
Table 39: earFold - Product Status 45
Table 40: earFold - Product Description 45
Table 41: Allergan Plc - Ongoing Clinical Trials Overview 46
Table 42: earFold - Long Term Prospective Uncontrolled Study of Earfold or the Treatment of Prominent Ears: FOLD 47
Table 43: Almirall Ltd Pipeline Products & Ongoing Clinical Trials Overview 48
Table 44: Hyaluronic Acid Facial Filler - Product Status 48
Table 45: Hyaluronic Acid Facial Filler - Product Description 48
Table 46: Ambicare Health Ltd Pipeline Products & Ongoing Clinical Trials Overview 49
Table 47: Ambulight Rejuvenate - Product Status 49
Table 48: Ambulight Rejuvenate - Product Description 49
Table 49: Andrew Technology LLC Pipeline Products & Ongoing Clinical Trials Overview 50
Table 50: HydraSolve Lipoplasty System - Visceral Fat - Product Status 50
Table 51: HydraSolve Lipoplasty System - Visceral Fat - Product Description 50
Table 52: Anika Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 51
Table 53: Next Generation ELEVESS Dermal Filler - Product Status 51
Table 54: Next Generation ELEVESS Dermal Filler - Product Description 51
Table 55: Apogee Aesthetic Technologies Pipeline Products & Ongoing Clinical Trials Overview 52
Table 56: G-Lift - Product Status 52
Table 57: G-Lift - Product Description 52
Table 58: Avita Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 53
Table 59: ReNovaCell - Aesthetics And Repigmentation - Product Status 53
Table 60: ReNovaCell - Aesthetics And Repigmentation - Product Description 53
Table 61: Avita Medical Ltd - Ongoing Clinical Trials Overview 54
Table 62: ReNovaCell - Aesthetics And Repigmentation - Autologous Cell Suspension Grafting Using ReNovacell in Non-segmental Vitiligo Patients: A Randomized Controlled Study 55
Table 63: ReNovaCell - Aesthetics And Repigmentation - Evaluation of Optimal Deployment of ReNovaCell in Subjects with Pigmentation Defects 55
Table 64: Bellus Medical, LLC Pipeline Products & Ongoing Clinical Trials Overview 56
Table 65: SkinPen Microneedling Cartridge - Product Status 56
Table 66: SkinPen Microneedling Cartridge - Product Description 56
Table 67: SkinPen Precision Microneedling Pen - Product Status 57
Table 68: SkinPen Precision Microneedling Pen - Product Description 57
Table 69: Bellus Medical, LLC - Ongoing Clinical Trials Overview 58
Table 70: SkinPen Microneedling Cartridge - A Single-center Trial to Evaluate the Efficacy and Tolerability of SkinPen on Male and Female Subjects' Acne Scars on the Face and/or Back 59
Table 71: BioPhotas, Inc. Pipeline Products & Ongoing Clinical Trials Overview 60
Table 72: Celluma - Skin Rejuvenation And Sun Spots - Product Status 60
Table 73: Celluma - Skin Rejuvenation And Sun Spots - Product Description 60
Table 74: Biosculpture Technology, Inc. Pipeline Products & Ongoing Clinical Trials Overview 61
Table 75: Airbrush Liposculptor IIE - Product Status 61
Table 76: Airbrush Liposculptor IIE - Product Description 61
Table 77: Airbrush Liposculptor IIIE - Product Status 62
Table 78: Airbrush Liposculptor IIIE - Product Description 62
Table 79: BioTime Inc Pipeline Products & Ongoing Clinical Trials Overview 63
Table 80: Renevia - Product Status 63
Table 81: Renevia - Product Description 64
Table 82: BioTime Inc - Ongoing Clinical Trials Overview 65
Table 83: Renevia - A Randomized, Evaluator-blinded, Delayed-treatment-controlled Study of the Effectiveness and Safety of Renevia, A Resorbable Matrix for the Delivery of Autologous Adipose Derived Cells to treat Subcutaneous Facial Lipoatrophy Defects Arising from HIV 66
Table 84: Bioxis Pharmaceuticals Pipeline Products & Ongoing Clinical Trials Overview 67
Table 85: Cytosial - Product Status 67
Table 86: Cytosial - Product Description 67
Table 87: Cytosmile - Product Status 68
Table 88: Cytosmile - Product Description 68
Table 89: MTI-12 - Product Status 68
Table 90: MTI-12 - Product Description 69
Table 91: Celltrix AB Pipeline Products & Ongoing Clinical Trials Overview 70
Table 92: Credurance - Product Status 70
Table 93: Credurance - Product Description 70
Table 94: Cutera Inc Pipeline Products & Ongoing Clinical Trials Overview 71
Table 95: enlighten 670nm Laser - Skin Rejuvenation - Product Status 71
Table 96: enlighten 670nm Laser - Skin Rejuvenation - Product Description 71
Table 97: enlighten 670nm Laser - Tattoo Removal - Product Status 72
Table 98: enlighten 670nm Laser - Tattoo Removal - Product Description 72
Table 99: Cutera Inc - Ongoing Clinical Trials Overview 73
Table 100: enlighten 670nm Laser - Skin Rejuvenation - Study of a Novel Laser for Skin Rejuvenation 74
Table 101: enlighten 670nm Laser - Tattoo Removal - An Open Label, Split-tattoo Study Comparing the Safety and Efficacy of the 670nm Picosecond Laser Versus the 755 nm Picosecond Laser for Tattoo Removal 75
Table 102: Cytophil, Inc. Pipeline Products & Ongoing Clinical Trials Overview 76
Table 103: Renu Soft Tissue Volumizing Filler - Aesthetic - Product Status 76
Table 104: Renu Soft Tissue Volumizing Filler - Aesthetic - Product Description 76
Table 105: Cytori Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 77
Table 106: Celution - Parry-Romberg's Disease - Product Status 77
Table 107: Celution - Parry-Romberg's Disease - Product Description 77
Table 108: Cytrellis Biosystems Inc Pipeline Products & Ongoing Clinical Trials Overview 78
Table 109: Aesthetic Device - Product Status 78
Table 110: Aesthetic Device - Product Description 78
Table 111: Dermele Skin Care, LLC Pipeline Products & Ongoing Clinical Trials Overview 79
Table 112: Gold Nanoparticle Dermal Filler - Product Status 79
Table 113: Gold Nanoparticle Dermal Filler - Product Description 79
Table 114: Eclipse Aesthetics LLC Pipeline Products & Ongoing Clinical Trials Overview 80
Table 115: Eclipse MicroPen Evo - Product Status 80
Table 116: Eclipse MicroPen Evo - Product Description 80
Table 117: Eclipse Reverse - Product Status 81
Table 118: Eclipse Reverse - Product Description 81
Table 119: Ellman International Inc Pipeline Products & Ongoing Clinical Trials Overview 82
Table 120: Radiage Wand RF Non-Ablative Handpiece - 15mm - Product Status 82
Table 121: Radiage Wand RF Non-Ablative Handpiece - 15mm - Product Description 82
Table 122: Energist Ltd Pipeline Products & Ongoing Clinical Trials Overview 83
Table 123: i-LipoXcell - Radiofrequency Skin Tightening - Product Status 83
Table 124: i-LipoXcell - Radiofrequency Skin Tightening - Product Description 83
Table 125: Erchonia Corp Pipeline Products & Ongoing Clinical Trials Overview 84
Table 126: Low Level Laser - Hair Restoration - Product Status 84
Table 127: Low Level Laser - Hair Restoration - Product Description 84
Table 128: Eternity Healthcare Inc. Pipeline Products & Ongoing Clinical Trials Overview 85
Table 129: Hand-held Laser Hair Removal Device - Product Status 85
Table 130: Hand-held Laser Hair Removal Device - Product Description 85
Table 131: EternoGen Aesthetics LLC Pipeline Products & Ongoing Clinical Trials Overview 86
Table 132: Collagen Scaffold - Aesthetic Procedures - Product Status 86
Table 133: Collagen Scaffold - Aesthetic Procedures - Product Description 86
Table 134: FibroGen Inc Pipeline Products & Ongoing Clinical Trials Overview 87
Table 135: FG-5030 - Product Status 87
Table 136: FG-5030 - Product Description 87
Table 137: Forticell Bioscience Inc Pipeline Products & Ongoing Clinical Trials Overview 88
Table 138: Haptized Collagen Tissue Augmentation - Product Status 88
Table 139: Haptized Collagen Tissue Augmentation - Product Description 88
Table 140: Fourth State Medicine Ltd Pipeline Products & Ongoing Clinical Trials Overview 89
Table 141: Nebulaskin - Product Status 89
Table 142: Nebulaskin - Product Description 89
Table 143: Galderma SA Pipeline Products & Ongoing Clinical Trials Overview 90
Table 144: Restylane Lidocaine - Product Status 90
Table 145: Restylane Lidocaine - Product Description 90
Table 146: Restylane Lyft - Hand Rejuvenation - Product Status 91
Table 147: Restylane Lyft - Hand Rejuvenation - Product Description 91
Table 148: Restylane Perlane - Product Status 91
Table 149: Restylane Perlane - Product Description 92
Table 150: Restylane Skinboosters Vital - Product Status 92
Table 151: Restylane Skinboosters Vital - Product Description 92
Table 152: Galderma SA - Ongoing Clinical Trials Overview 93
Table 153: Restylane Perlane - A Randomized, Multi-center, Evaluator-blinded, No-treatment Controlled Study to Evaluate the Efficacy and Safety of Restylane Perlane Lidocaine for Correction of Midface Volume Deficit And/Or Midface Contour Deficiency 94
Table 154: Restylane Perlane - A Randomized, Multi-center, Subject and Evaluator-blinded Study Comparing the Pain and the Safety Profile Associate with Correction of Moderate to Severe Nasolabial Folds Using Restylane Perlane Lidocaine Compared to Restylane Perlane 94
1.2 List of Figures
Figure 1: Aesthetic Devices - Pipeline Products by Stage of Development 20
Figure 2: Aesthetic Devices - Pipeline Products by Segment 21
Figure 3: Aesthetic Devices - Pipeline Products by Territory 22
Figure 4: Aesthetic Devices - Pipeline Products by Regulatory Path 23
Figure 5: Aesthetic Devices - Pipeline Products by Estimated Approval Date 24
Figure 6: Aesthetic Devices - Ongoing Clinical Trials 25
